Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brett P Monia

Showing results (81-90 of 147) with videos related to

Pageof 15
Sort By:
Molecular Cancer Therapeutics|November 16, 2004
Disruption of WT1 gene expression and exon 5 splicing following cytotoxic drug treatment: antisense down-regulation of exon 5 alters target gene expression and inhibits cell survivalJane Renshaw, Rosanne M Orr, Michael I Walton, et al.
Blood|August 20, 2015
Genetic diminution of circulating prothrombin ameliorates multiorgan pathologies in sickle cell disease miceParitha I Arumugam, Eric S Mullins, Shiva Kumar Shanmukhappa, et al.
Diabetes|December 20, 2014
Transthyretin Antisense Oligonucleotides Lower Circulating RBP4 Levels and Improve Insulin Sensitivity in Obese MiceLaura Zemany, Sanjay Bhanot, Odile D Peroni, et al.
Archives of Biochemistry and Biophysics|November 22, 2008
PKCepsilon plays a causal role in acute ethanol-induced steatosisJ Phillip Kaiser, Juliane I Beier, Jun Zhang, et al.
Immunobiology|August 27, 2015
Inhibition of the alternative complement pathway by antisense oligonucleotides targeting complement factor B improves lupus nephritis in miceTamar R Grossman, Lisa A Hettrick, Robert B Johnson, et al.
The Journal of Clinical Investigation|February 24, 2007
Inhibition of protein kinase Cepsilon prevents hepatic insulin resistance in nonalcoholic fatty liver diseaseVarman T Samuel, Zhen-Xiang Liu, Amy Wang, et al.
Hepatology (Baltimore, Md.)|January 12, 2012
Inhibition of hepatic sulfatase-2 in vivo: a novel strategy to correct diabetic dyslipidemiaH Carlijne Hassing, Hans Mooij, Shuling Guo, et al.
Hepatology (Baltimore, Md.)|July 8, 2005
Antisense oligonucleotide reduction of DGAT2 expression improves hepatic steatosis and hyperlipidemia in obese miceXing Xian Yu, Susan F Murray, Sanjay K Pandey, et al.
Cancer Research|August 5, 2015
Colon Cancer Growth and Dissemination Relies upon Thrombin, Stromal PAR-1, and FibrinogenGregory N Adams, Leah Rosenfeldt, Malinda Frederick, et al.
American Journal of Respiratory Cell and Molecular Biology|March 6, 2019
Nonsense-mediated RNA Decay Pathway Inhibition Restores Expression and Function of W1282X CFTRMelissa M Keenan, Lulu Huang, Nikole J Jordan, et al.
Pageof 15

Showing results (81-90 of 147) with videos related to

Sort By:
Pageof 15
Molecular Cancer Therapeutics|November 16, 2004
Disruption of WT1 gene expression and exon 5 splicing following cytotoxic drug treatment: antisense down-regulation of exon 5 alters target gene expression and inhibits cell survivalJane Renshaw, Rosanne M Orr, Michael I Walton, et al.
Blood|August 20, 2015
Genetic diminution of circulating prothrombin ameliorates multiorgan pathologies in sickle cell disease miceParitha I Arumugam, Eric S Mullins, Shiva Kumar Shanmukhappa, et al.
Diabetes|December 20, 2014
Transthyretin Antisense Oligonucleotides Lower Circulating RBP4 Levels and Improve Insulin Sensitivity in Obese MiceLaura Zemany, Sanjay Bhanot, Odile D Peroni, et al.
Archives of Biochemistry and Biophysics|November 22, 2008
PKCepsilon plays a causal role in acute ethanol-induced steatosisJ Phillip Kaiser, Juliane I Beier, Jun Zhang, et al.
Immunobiology|August 27, 2015
Inhibition of the alternative complement pathway by antisense oligonucleotides targeting complement factor B improves lupus nephritis in miceTamar R Grossman, Lisa A Hettrick, Robert B Johnson, et al.
The Journal of Clinical Investigation|February 24, 2007
Inhibition of protein kinase Cepsilon prevents hepatic insulin resistance in nonalcoholic fatty liver diseaseVarman T Samuel, Zhen-Xiang Liu, Amy Wang, et al.
Hepatology (Baltimore, Md.)|January 12, 2012
Inhibition of hepatic sulfatase-2 in vivo: a novel strategy to correct diabetic dyslipidemiaH Carlijne Hassing, Hans Mooij, Shuling Guo, et al.
Hepatology (Baltimore, Md.)|July 8, 2005
Antisense oligonucleotide reduction of DGAT2 expression improves hepatic steatosis and hyperlipidemia in obese miceXing Xian Yu, Susan F Murray, Sanjay K Pandey, et al.
Cancer Research|August 5, 2015
Colon Cancer Growth and Dissemination Relies upon Thrombin, Stromal PAR-1, and FibrinogenGregory N Adams, Leah Rosenfeldt, Malinda Frederick, et al.
American Journal of Respiratory Cell and Molecular Biology|March 6, 2019
Nonsense-mediated RNA Decay Pathway Inhibition Restores Expression and Function of W1282X CFTRMelissa M Keenan, Lulu Huang, Nikole J Jordan, et al.
Pageof 15